| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 10%+ Owner | ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK | Johnson & Johnson By /s/ Marc Larkins, Secretary | 10 Nov 2025 | 0000200406 |
| Johnson & Johnson Innovation - JJDC, Inc. | 10%+ Owner | 410 GEORGE STREET, NEW BRUNSWICK | Johnson & Johnson Innovation - JJDC, Inc. By: /s/ Jill McManus, Assistant Treasurer | 10 Nov 2025 | 0000924020 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVRX | Common Stock | Sale | $534,310 | -52,332 | -1.3% | $10.21 | 4,051,098 | 06 Nov 2025 | By Johnson & Johnson Innovation - JJDC, Inc. | F1, F2 |
| transaction | CVRX | Common Stock | Sale | $2,000 | -200 | -0% | $10.00 | 4,050,898 | 07 Nov 2025 | By Johnson & Johnson Innovation - JJDC, Inc. | F2 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.49. The Reporting Persons undertake to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson. |